Tandem Diabetes Care
TNDM
388 hedge funds and large institutions have $9.07B invested in Tandem Diabetes Care in 2021 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 140 increasing their positions, 116 reducing their positions, and 30 closing their positions.
190% more first-time investments, than exits
New positions opened: 87 | Existing positions closed: 30
38% more call options, than puts
Call options by funds: $105M | Put options by funds: $75.6M
24% more capital invested
Capital invested by funds: $7.32B → $9.07B (+$1.76B)
21% more repeat investments, than reductions
Existing positions increased: 140 | Existing positions reduced: 116
15% more funds holding
Funds holding: 337 → 388 (+51)
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
2.13% less ownership
Funds ownership: 97.25% → 95.11% (-2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$90.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$79M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$64.8M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$37.8M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$33.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$144M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$75.7M |
| 3 |
Jennison Associates
New York
|
-$38.2M |
| 4 |
Amundi
Paris,
France
|
-$37M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.2M |
TNDM Hedge Fund Activity: Q4 2021 in Review
388 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q4 2021, worth a combined $9.07B — up 24% from $7.32B a quarter earlier.
Buyers outnumbered sellers: 87 funds opened new TNDM positions and 30 closed out — a net gain of 57 holders — while 140 added to existing stakes and 116 trimmed.
The largest buyer was BlackRock, adding an estimated $90.7M. The largest seller was Jackson Square Partners, cutting an estimated $144M.
- 388 institutional investors held Tandem Diabetes Care (TNDM) as of Q4 2021, up from 337 in Q3 2021.
- Funds reported $9.07B of Tandem Diabetes Care stock for Q4 2021, up 24% quarter-over-quarter.
- 87 funds opened new Tandem Diabetes Care positions in Q4 2021 and 30 closed out, a net change of +57 holders.
- The largest Tandem Diabetes Care buyer in Q4 2021 was BlackRock, an estimated $90.7M added.
- The largest Tandem Diabetes Care seller in Q4 2021 was Jackson Square Partners, an estimated $144M sold.
Based on aggregated 13F filings for Q4 2021.